Search | TVST | ARVO Journals

Showing 1 – 20 of 62

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Human biorepository for imaging and molecular analysis of Diabetic Retinal Disease: An update of the Mary Tyler Moore Vision Initiative

Patrice E Fort; Kelli Ramos; Corey M Porter; Carmen Yu; Thomas W Gardner; Jennifer K Sun; S Robert Levine

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):858.

ARVO Annual Meeting Abstract June 2024

Understanding Macula-Off Rhegmatogenous Retinal Detachment through Vitreous Proteomics

Sarah Weber; Mireille Caton-Darby; Jeffrey Yu; Nicholas J. Carruthers; Christopher Gates; Tanya Marrocco-Redmond; Thomas W. Gardner; David N. Zacks; Yuanjun Zhao; Jeffrey Sundstrom

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):649.

ARVO Annual Meeting Abstract June 2024

Sight-Saving Engagement and Evaluation in New Haven (SEEN) Program Engages Individuals with Excellent Vision at High-Risk for Blindness from Diabetic Retinopathy

Kristen Harris Nwanyanwu; Akua Frimpong; Julia Jieyu Fu; Thomas Chang; Brittany Assanah; June Weiss; Joana Andoh; Mayur Desai; Thomas W Gardner; Marcella Nunez-Smith

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1778.

Research Opportunities November 2023

Report From the 2022 Mary Tyler Moore Vision Initiative Diabetic Retinal Disease Clinical Endpoints Workshop

PDF

S. Robert Levine; Martin G. Myers; Ryan Barunas; Dolly S. Chang; Sanjoy Dutta; Ted Maddess; Jeffrey M. Liebmann; Steve Sherman; Melvina Eydelman; Jennifer K. Sun; Wiley Chambers; Kerstin Wickström; Ulrich F. O. Luhmann; Martin Pallinat; Adam Glassman; Lloyd Paul Aiello; Dorene S. Markel; Thomas W. Gardner
TAGS: diabetes mellitus, retinal diseases, surrogate endpoints, vision
Trans. Vis. Sci. Tech.. 2023; 12(11):33. https://doi.org/10.1167/tvst.12.11.33

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2023

Validation of a Targeted Proteomic Assay to Increase Coverage of the Vitreous Proteome

Sarah Weber; Thomas W Gardner; Chris Gates; Nick Carruthers; David N Zacks; Jeffrey Yu; Yuanjun Zhao; Jeffrey Sundstrom

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):5285.

ARVO Annual Meeting Abstract June 2022

Vitreous Biopsy Device and Potential Change in Practice Patterns in Patients with Infectious and Non-Infectious Uveitis

Sarah Weber; Thomas W. Gardner; Lauro V Ojeda; Thomas Marten; Jeffrey Plott; David F Harris; Jeffrey Sundstrom

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):697 – F0222.

ARVO Annual Meeting Abstract June 2022

Updating the Diabetic Retinal Disease Staging System through the Restoring Vision Moonshot™

Jennifer K Sun; Thomas W. Gardner; Michael David Abramoff; Lloyd P Aiello; Helen Colhoun; Adam R Glassman; Tien-En Tan; Tien Wong; Stela Vujosevic; Sanjoy Dutta; S. Robert Levine

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2207 – F0270.

ARVO Annual Meeting Abstract June 2022

Relation between type I diabetes duration and capillary density in the macula

Marie Elise Wistrup Torm; Jesper Johannesen; Thomas W. Gardner; Javad Hajari; Oliver Niels Klefter; Michael Larsen

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2895 – F0048.

ARVO Annual Meeting Abstract June 2021

A Validated Analysis Pipeline for Vitreous Proteomics

Sarah Weber; Venkatesha Basrur; Felipe Da Veiga Leprevost; Alexey Nesvizhskii; Christopher Gates; Jingqun Ma; Yuanjun Zhao; Thomas W. Gardner; Jeffrey M. Sundstrom

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3129.

ARVO Annual Meeting Abstract June 2021

High fat diets, but not high sucrose diets, cause a loss of retinal protein malonylation

Steven F Abcouwer; Sumathi Shanmugam; William Kardasis; Phil Kish; Patrice E Fort; Thomas W Gardner; Amy E Rumora; Eva Feldman; Judy Baek; Subramanium Pennathur

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3133.

ARVO Annual Meeting Abstract June 2021

Inactivation of Mechanistic Target of Rapamycin Complex 1 Results in Loss of Retinal Ganglion cells

Dejuan Kong; Lynda Elghazi; Heather Hager; Mandy Losiewicz; Sumathi Shanmugam; Patrice E Fort; Thomas W Gardner; Steven F Abcouwer

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1461.

ARVO Annual Meeting Abstract June 2020

Comparison of Methods for Quantification of Kinetic Visual Field Areas

Natalie Dakki; Gislin Dagnelie; Thomas W Gardner; Naheed W Khan

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3022.

ARVO Annual Meeting Abstract June 2020

Biologic and technical reproducibility in proteomic analyses of human vitreous.

Sarah Weber; Venkatesha Basrur; Alexey I. Nesvizhskii; Chris Gates; Yuanjun Zhao; Thomas W Gardner; Jeffrey Sundstrom

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):5005.

Articles February 2020

Treated PDR Reveals Age-Appropriate Vision Deterioration But Distorted Retinal Organization

PDF

Xing D. Chen; Amro Omari; Min Hwang; Leon Kwark; Natalie Dakki; Sina Farsiu; Thomas W. Gardner
TAGS: proliferative diabetic retinopathy, vision, diabetes mellitus, eye
Trans. Vis. Sci. Tech.. 2020; 9(3):3. https://doi.org/10.1167/tvst.9.3.3

Includes: Supplemental Content

Articles July 2019

Patient-Reported Outcomes Reveal Impairments Not Explained by Psychophysical Testing in Patients With Regressed PDR

PDF

Xing D. Chen; Thomas W. Gardner
TAGS: patient self-report, psychophysics, vision, visual acuity, eye, visual fields
Trans. Vis. Sci. Tech.. 2019; 8(4):11. https://doi.org/10.1167/tvst.8.4.11

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2019

Retinal Ganglion Cell Protein Synthesis is Regulated by Glycolysis, mTORC1 Signaling, and Diabetes

Mandy Losiewicz; Lynda Elghazi; Dejuan Kong; Diane Fingar; Raju V S Rajala; Patrice E Fort; Steven F Abcouwer; Thomas W Gardner

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6429.

ARVO Annual Meeting Abstract July 2019

Natural History of Visual Function Impairment in Patients Post-treatment with Pan-retinal Photocoagulation for Proliferative Diabetic Retinopathy

Xing Chen; Amro Omari; Min Hwang; Thomas W Gardner

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6556.

ARVO Annual Meeting Abstract July 2019

Effects of diabetes on retinal protein lysine malonylation

Steven F Abcouwer; Sumathi Shanmugam; Heather Hager; Cheng-mao Lin; Thomas W Gardner; Patrice E Fort; Kelli M. Sas; Subramaniam Pennathur

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2678.

ARVO Annual Meeting Abstract July 2019

Retinal degenerative diseases alter vitreous protein and extracellular vesicle concentrations.

Sarah Weber; Yuanjun Zhao; Thomas W Gardner; Jeffrey M Sundstrom

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4948.

ARVO Annual Meeting Abstract July 2019

Roles of Mechanistic Target of Rapamycin Complexes in Retinal Development and Visual Function

Dejuan Kong; Heather Hager; Sumathi Shanmugam; Lynda Elghazi; Patrice E Fort; Thomas W Gardner; Steven F. Abcouwer

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6032.

1 2 3 4

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Filters

Specify Date Range

Human biorepository for imaging and molecular analysis of Diabetic Retinal Disease: An update of the Mary Tyler Moore Vision Initiative

Understanding Macula-Off Rhegmatogenous Retinal Detachment through Vitreous Proteomics

Sight-Saving Engagement and Evaluation in New Haven (SEEN) Program Engages Individuals with Excellent Vision at High-Risk for Blindness from Diabetic Retinopathy

Report From the 2022 Mary Tyler Moore Vision Initiative Diabetic Retinal Disease Clinical Endpoints Workshop

Validation of a Targeted Proteomic Assay to Increase Coverage of the Vitreous Proteome

Vitreous Biopsy Device and Potential Change in Practice Patterns in Patients with Infectious and Non-Infectious Uveitis

Updating the Diabetic Retinal Disease Staging System through the Restoring Vision Moonshot™

Relation between type I diabetes duration and capillary density in the macula

A Validated Analysis Pipeline for Vitreous Proteomics

High fat diets, but not high sucrose diets, cause a loss of retinal protein malonylation

Inactivation of Mechanistic Target of Rapamycin Complex 1 Results in Loss of Retinal Ganglion cells

Comparison of Methods for Quantification of Kinetic Visual Field Areas

Biologic and technical reproducibility in proteomic analyses of human vitreous.

Treated PDR Reveals Age-Appropriate Vision Deterioration But Distorted Retinal Organization

Patient-Reported Outcomes Reveal Impairments Not Explained by Psychophysical Testing in Patients With Regressed PDR

Retinal Ganglion Cell Protein Synthesis is Regulated by Glycolysis, mTORC1 Signaling, and Diabetes

Natural History of Visual Function Impairment in Patients Post-treatment with Pan-retinal Photocoagulation for Proliferative Diabetic Retinopathy

Effects of diabetes on retinal protein lysine malonylation

Retinal degenerative diseases alter vitreous protein and extracellular vesicle concentrations.

Roles of Mechanistic Target of Rapamycin Complexes in Retinal Development and Visual Function

To View More...

You must be signed into an individual account to use this feature.